Fluidigm, SAS | GenomeWeb

Fluidigm, SAS

Premium
Fluidigm this week launched its BioMark 96.96 Dynamic Array, an integrated fluidic circuit capable of performing 9,216 simultaneous real-time PCR experiments running TaqMan assays in nanoliter quantities.
 
According to Fluidigm, 96.96 Dynamic Arrays can be used in gene expression studies to identify or validate large panels of genes that might predict cancer progression or help determine treatment options.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.